Anastasia I. Kapsoritaki

Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease

Konstantinos Oikonomou, Andreas Kapsoritakis, Anastasia I. Kapsoritaki et al. · Inflammatory Bowel Diseases · 2010 · 62 citations · Full text

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

Anastassios C. Manolakis, Andreas Kapsoritakis, Panagiotis Georgoulias et al. · BMC Gastroenterology · 2010 · 47 citations · Full text

Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease

Andreas Kapsoritakis, Anastasia I. Kapsoritaki, Ioanna P Davidi et al. · BMC Gastroenterology · 2008 · 46 citations · Full text

Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?

Konstantinos Oikonomou, Andreas Kapsoritakis, Anastasia I. Kapsoritaki et al. · Growth Factors · 2010 · 25 citations

Readressing the Role of Toll-Like Receptor-4 Alleles in Inflammatory Bowel Disease: Colitis, Smoking, and Seroreactivity

Anastassios C. Manolakis, Andreas Kapsoritakis, Anastasia I. Kapsoritaki et al. · Digestive Diseases and Sciences · 2012 · 13 citations

Inflammation, Toll-like Receptors, Toll-like Receptor-4 Alleles +6